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POSTER SESSION 1037-25 One-Year Clinical and Echocardiographic Follow-Up 
After Endocardial Radiofrequency Ablation for Atrial 
Fibrillation During Mitral Valve Surgery 
Georges Fayad, Thierry Le Tourneau, Thomas Modine. Richard Azzaoui, Benoit Larrue. 
Doroth& Koussa, Gassan Naja. Christophe Decoenne, Henri Warembourg, Cardiologic 
Hospital, Lille, France 
Background : Atrial fibrillatkx? (AF) is associated with adverse events particularly in mitral 
valve (MV) disease. Surgical radiofrequency (RF)ablation might be an interesting alter- 
native to the Maze procedure for treatment of AF in MV disease. Methods: Over the past 
two years. 58 patients (pts, 65+10 years) operated on for mitral regurgitation (36) or 
stenosis (22) with either chronic (41) or paroxystlc (17) AF benefited in the same time for 
RF ablation. RF ablation was realized on the endocardial layer using a eight tip RF 
probe. Cardiac rhythm was evaluated at 3. 6 and 12 months with clinlcal examination, 
patient questtonlng, and ECG. A 24 hours ECG record was performed after 6 months. 
Echocardiographlc examination, including left and right atrial function. tricuspid and 
mitral transvalvular flow velocities was performed before operation, 7 days, 3 months, 
and within 1 years after operation. Results: Pts of the chronic group were significantly 
older, had a longer period of AF (p=O.O2) and a greater left atrium (p=O,OO3) compared 
with the paroxystlc group. Surgical RF ablation was performed in the left atria (55) or in 
both atriums (3). MV surgery consisted in MV repair I” 11 pts, and MV replacement in 47 
pts (mechanical prosthesis. 28, bloprosthesis: 19). Mean antiarythmlc procedure duration 
was 19i6 min, and aortic cross clamp time 121+27 min. Post-operative complications 
were 1 death from multiorgan failure, 1 permanent atrioventricular block requiring a pace- 
maker implantation, and a circonflex artery stenosis. At 6 months 67% Of pts were free of 
arrythmia, 33% experienced at least one access of supraventricular arrythmia, and only 
12% had several recurrences. Antiarrythmic drugs were withdrawn in 25% of pts. Left 
and right atrial contraction were effective in 84% of pts on the basis of doppler transval- 
vular A wave. Conclwon: RF ablation for AF during MV surgery is an effective and sim- 
ple procedure resulting in persistent smus rhythm after 1 year. This procedure preserve 
atrlal contraction and might allow wthdrawal of antiarrythmic and anttcoagulant drugs. 
1037-26 Predictors of Saphenous Vein Graft Patency: A Risk 
Assessment Based on a Longitudinal Analysis of 100 
Consecutive Post-Coronary Bypass Angiographic 
Studies 
Todd K. Rosenaart Eileen B. Finnin. Stack? A. Hudgens, Elizabeth A. Hahn, Ronald D. 
Curran, Timothy V. Votapka, Michael W. Frank, Thomas G. Frohlich. Michael H. 
Salinger, Timothy J. McDonough, Theodore E. Feldman, Timothy A. Sanborn, Evanston 
Northwestern Healthcare, Evanston, IL 
Background: Saphenous vein graft (SVG) occlusion remains a persistent complication of 
coronary bypass grafting (CABG). Conduits such as the internal mammary and radial 
arteries have been promoted as useful alternatives to SVG bypasses, a risk profile useful 
I” delineating contributors to SVG occlusion would consequently be helpful in planning 
for the use of alternative conduits. 
Methods: Potential predictors of SVG occlusion were evaluated for all patients (M:F, 
69:31; mean age = 64 + 11 years) undergoing CABG at our institution since 1995. Post- 
CABG anglographic data were added to a prospectively maintained database(n=lOO 
patients, total number of grafts=318). Patients were included in this study if the graft tar- 
get territory was a vein (left anterior descending (LAD), circumflex (Cx). right coronary 
artery (RCA)) rather than an alternative arterial conduit (right and left internal mamma- 
ries). The generaltzed estimating equation method was implemented to evaluate risk fac- 
tors for SVG occlusion (partial/full occlusion vs. patent). Potential graft-and patient- 
specific risk factors for occlusion included: target artery caliber (<=1.5 vs. 2.0). vein qual- 
ity (poor/fair vs. good), graft target territory , gender, age, ejection fraction (50), diabetes, 
obesity. family history, hypercholesterolemia. smoking, and hypertension. 
Results: Median time to post-op cath was 24 2 22 months (interquartile range, 6-37 
months). Median SVG patency was 50% (O-100%). compared to internal mammary 
artery patency of 91%. Target graft territory was associated with increased SVG occlu- 
sion: unadjusted odds ratio Cx vs. LAD, 1.56 (95% C.l.=O.75-3.27); RCA vs. LAD, 0.70 
(0.36-I 35); Cx vs. RCA, 2.24 (1.22-4.10). The only other vein specific risk factor for 
occlusion was vein quality: unadjusted odds ratio, 1.6 (0.89-2.86). Patient-specific risk 
factors wth a trend towards association (p < 0.25) with increased SVG occlusion 
included: gender (female vsmale). 1.87 (0.99-3.56); diabetes, 1.72 (0.88-3.35); and fam- 
ily hlstory. 1.45 (0.80, 2.65). 
Conclusions: Alternative conduits should be considered for saphenous vein grafts with a 
poor likelihood of patency. 
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1059-21 Increased Presence of Pathogen Burden and of 
Circulatory Precursor Cells in Prosthetic Compared to 
Native Degenerated Aortic Valves 
Gerhard Bauriedel, Kristina Yeahiazaryan Dirk Skowasch, Stefanie Schrempf, Claus J. 
Preusse, Armin Welz, Berndt Liideritz, Heart Center University of Bonn. Bonn, Germany 
Background: Based on the concept of chronic valvular infections, the present study 
sought to assess the presence of Chlamydia pneumoniae(chlamydial heat shock protein 
60), Helicobacter py/ori (HP), Cyiomegalovirus (CMV), Herpes simplex virus (HSV) and 
Epstein-Barr virus (EBV), as well as the possible association between this pathogen bur- 
den on inflammation (CD68, CD3, CRP) in valvular degeneration of native versus blc- 
prosthetic valves. In addition, circulatory precursor cells (CD34, CD133) that might 
contribute as repair cells were evaluated. Methods: Serial sections of degenerated 
native (n=57) and prosthetic (n=23) aortic valves were analyzed by immunohistochemis- 
try and computer-aided morphometry for the presence of these determinants. Results: 
Degenerated aortic valves revealed prevalence of Chlamydia penumoniae in 65%, of 
CMV in 66%, of HP in 80%, of HSV in 76% and of EBV in 68%, while immunoreactive 
CD68 was present in 79%, CD3 I” 66% and CRP in 58%. CD34 and CD133 were 
observed in all valves. Quantitatively, presence of pathogens (each P<O.OOl) as well as 
markers of inflammation (CD68: 34.2229.7% vs. 3.4+_4.3%, P<O.OOl; CRP: 7X1+13.8% 
vs. 2.1+4.2%; P<O.Oi) and precursor cells (CD34: 18.1_+25.0% vs. 5.7+13.4%, P=O.O14; 
CD133: 12.4113.2 vs. 5.6+8.5%, P=O.Oll) were significantly increased I” prosthetic 
compared to native valves. Microorganisms correlated significantly with markers of 
inflammation. When categorizing into valves burdend by 4 or 5 pathogens (n=49) and 
into valves wth < 4 microorgansisms (n=31), increased signaling of CD68, CD3 and CRP 
were observed in the first group (P<O.OOl). 
Conclusions: Valvular infection, inflammation and circulatory progenitor cells are fre- 
quently found in degenerated aortic valves. Their differential presence of the non-valvular 
cells in native and prosthetic valves suggest ccmm~n pathomechanlsms and a mwe 
important role for prosthetic degeneration. Correlation of pathogens with macrophages 
and CRP I” valvular fibrosa point to regional stressor effects that might be, at least partly, 
attributable to cumulative pathogen burden. 
1059-22 Autocrine-Paracrine Factors Released by Cardiac 
Fibroblasts Stimulate Abnormal Myocardial Fibronectin 
Synthesis in Aortic Regurgitation 
Sharada L. Truter, Eungsuk Lee, Zhen S. Huang. Jennifer A. Lee, Jeffrey S. Borer, Weill 
Medical College of Cornell Unwrsity, New York, NY 
Background: Chronic aortlc regurgitation (AR) in patients (pts) and in NZW rabbits (R) 
with surgically-induced experimental AR causes extensive myocardial fibrosis contribut- 
ing to heart failure (CHF). We demonstrated experimentally and in pts that AR fibrosis 
results from abnormal expression of fibronectin (FN) and other glycoproteins. but not eol- 
lagen, by cardiac fibroblasts (CF). However, FN hyperexpression continues I” CF culture 
even after AR-strain is removed. Thus, AR-CF may propagate FN excess by secreting 
FN-stimulators that persist.Methods: To seek these, CF were cultured from NZWR with- 
out (n=3) and with surgically induced AR (n=3). NL-CF cultures (passage 6) were ~ncu- 
bated with medium conditioned (ARCM) by AR-CF and fractionated with 30, 50 and 
1 OOkD filter columns, and in medium conditioned by NL-CF (NLCM). After 24 hrs, NL-CF 
media and lysates were assayed for FN. Results: By Western analysis, FN-expression 
by NL-CF Incubated with c1OOkD ARCM fractions was upregulated [1.7:1, p=O.O4] vs 
NL-CF in NLCM (Table), but FN upregulation was absent in NL-CF grown in <50kD or < 
30kD ARCM (Table). As in our earlier reports, FN was upregulated when AR-CF were 
grown in their own <iOOkD CM (AR:NL=3.4:1, pc.01). 
Conclusion: Chronic AR causes CF to release autocrine/paracrine factor(s) sized 50 to 
100 kD, that stimulate FN in NL-CF and may propagate FN uprsgulatlon in culture many 
passages after removal of AR stresses. These factors may be targets for novel therapies 
to prevent myocardlal fibrosis and CHF I” AR. 
FN Expression 
(NL-CF in ARCM: NL-CF in NLCM ) 
Cell Line AR-RF(%) ARCM <30kD ARCM <SOkD ARCM <lOOkD 
NL-CFI 14 0.3:1 0.9.1 1.3:l 
NL-CFZ 25 0 9:i 1.5:l 1.6:l 
NL-CF3 72 0.5:l 0.8:l 2.l:l 
Average 0.6:l (pc.04) 1.2:l (NS) 1.7:1 (PC.04) 
